Latest ArticlesEN-USTue, 04 Aug 2015 22:22:16 -0400503552
http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/AAhlTJoKy3w/even-with-recent-declines-investors-still-love-biotech-etfs-cm503552
Even With Recent Declines, Investors Still Love Biotech ETFsBiotechnology exchange traded funds still dominate the list of this year's top performing non leveraged sector ETFs. In fact, each of the top six sector ETFs in terms of year to date gains are biotech funds, but<img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/AAhlTJoKy3w" height="1" width="1" alt=""/>Fri, 31 Jul 2015 11:11:48 Z2015-07-31T11:11:48Zhttp://www.nasdaq.com/article/even-with-recent-declines-investors-still-love-biotech-etfs-cm503552503181
http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6Zh9pOaX0bk/fbt-amgn-tech-nktr-etf-inflow-alert-cm503181
FBT, AMGN, TECH, NKTR: ETF Inflow AlertLooking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel , one standout is the First Trust NYSE Arca Biotechnology Index Fund (Symbol FBT) where we have detected an approximate $56.2<img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/6Zh9pOaX0bk" height="1" width="1" alt=""/>Thu, 30 Jul 2015 16:30:22 Z2015-07-30T16:30:22Zhttp://www.nasdaq.com/article/fbt-amgn-tech-nktr-etf-inflow-alert-cm503181500595
http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FxkOgDJNF64/notable-two-hundred-day-moving-average-cross-cphd-cm500595
Notable Two Hundred Day Moving Average Cross - CPHDIn trading on Friday, shares of Cepheid (Symbol CPHD) crossed below their 200 day moving average of $55.28, changing hands as low as $53.01 per share. Cepheid shares are currently trading off about 12.2% on the day. The chart<img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/FxkOgDJNF64" height="1" width="1" alt=""/>Fri, 24 Jul 2015 17:30:47 Z2015-07-24T17:30:47Zhttp://www.nasdaq.com/article/notable-two-hundred-day-moving-average-cross-cphd-cm500595495342
http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/UeQe338lrFA/use-options-for-a-chance-to-buy-alny-at-a-37-discount-cm495342
Use Options For a Chance To Buy ALNY at a 37% DiscountLooking back to 171 days ago, Alnylam Pharmaceuticals Inc (Symbol ALNY) priced a 4,736,842.00 share secondary stock offering at $95 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go<img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/UeQe338lrFA" height="1" width="1" alt=""/>Fri, 10 Jul 2015 17:25:50 Z2015-07-10T17:25:50Zhttp://www.nasdaq.com/article/use-options-for-a-chance-to-buy-alny-at-a-37-discount-cm495342492913
http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/iJNYcvwKCLw/crl-makes-notable-cross-below-critical-moving-average-cm492913
CRL Makes Notable Cross Below Critical Moving AverageIn trading on Thursday, shares of Charles River Laboratories International Inc. (Symbol CRL) crossed below their 200 day moving average of $69.44, changing hands as low as $68.67 per share. Charles River Laboratories International Inc. shares are currently trading<img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/iJNYcvwKCLw" height="1" width="1" alt=""/>Thu, 02 Jul 2015 17:25:47 Z2015-07-02T17:25:47Zhttp://www.nasdaq.com/article/crl-makes-notable-cross-below-critical-moving-average-cm492913490184
http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/dXiqNIsV-II/bullish-two-hundred-day-moving-average-cross-nktr-cm490184
Bullish Two Hundred Day Moving Average Cross - NKTRIn trading on Wednesday, shares of Nektar Therapeutics (Symbol NKTR) crossed above their 200 day moving average of $13.15, changing hands as high as $13.50 per share. Nektar Therapeutics shares are currently trading up about 7% on the day.<img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/dXiqNIsV-II" height="1" width="1" alt=""/>Wed, 24 Jun 2015 17:29:41 Z2015-06-24T17:29:41Zhttp://www.nasdaq.com/article/bullish-two-hundred-day-moving-average-cross-nktr-cm490184486599
http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/f-Bj-_iq_vI/fridays-etf-movers-fm-fbt-cm486599
Friday's ETF Movers: FM, FBTIn trading on Friday, the iShares MSCI Frontier 100 ETF ( FM ) is outperforming other ETFs, up about 1% on the day. Components of that ETF showing particular strength include shares of Petrobras Argentina ( PZE ), trading<img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/f-Bj-_iq_vI" height="1" width="1" alt=""/>Fri, 12 Jun 2015 19:21:45 Z2015-06-12T19:21:45Zhttp://www.nasdaq.com/article/fridays-etf-movers-fm-fbt-cm486599486156
http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0Gkqt6zorqY/use-options-for-a-chance-to-buy-alny-at-a-35-discount-cm486156
Use Options For a Chance To Buy ALNY at a 35% DiscountLooking back to 142 days ago, Alnylam Pharmaceuticals Inc (Symbol ALNY) priced a 4,736,842.00 share secondary stock offering at $95 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go<img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/0Gkqt6zorqY" height="1" width="1" alt=""/>Thu, 11 Jun 2015 17:20:26 Z2015-06-11T17:20:26Zhttp://www.nasdaq.com/article/use-options-for-a-chance-to-buy-alny-at-a-35-discount-cm486156483160
http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_vVqDEeQ1N8/use-options-for-a-chance-to-buy-exas-at-a-37-discount-cm483160
Use Options For a Chance To Buy EXAS at a 37% DiscountLooking back to 169 days ago, EXACT Sciences Corp. (Symbol EXAS) priced a 4,000,000 share secondary stock offering at $25.75 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go<img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/_vVqDEeQ1N8" height="1" width="1" alt=""/>Wed, 03 Jun 2015 16:51:44 Z2015-06-03T16:51:44Zhttp://www.nasdaq.com/article/use-options-for-a-chance-to-buy-exas-at-a-37-discount-cm483160480955
http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/q8a8QYQ51Vs/use-options-for-a-chance-to-buy-agio-at-a-25-discount-cm480955
Use Options For a Chance To Buy AGIO at a 25% DiscountLooking back to 168 days ago, Agios Pharmaceuticals Inc (Symbol AGIO) priced a 1,986,455 share secondary stock offering at $110.75 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go<img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/q8a8QYQ51Vs" height="1" width="1" alt=""/>Wed, 27 May 2015 16:57:07 Z2015-05-27T16:57:07Zhttp://www.nasdaq.com/article/use-options-for-a-chance-to-buy-agio-at-a-25-discount-cm480955480941
http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fPoW6Z6ow7M/use-options-for-a-chance-to-buy-nvax-at-a-44-discount-cm480941
Use Options For a Chance To Buy NVAX at a 44% DiscountLooking back to 62 days ago, Novavax, Inc. (Symbol NVAX) priced a 24,137,931 share secondary stock offering at $7.25 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up<img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/fPoW6Z6ow7M" height="1" width="1" alt=""/>Wed, 27 May 2015 16:55:53 Z2015-05-27T16:55:53Zhttp://www.nasdaq.com/article/use-options-for-a-chance-to-buy-nvax-at-a-44-discount-cm480941475387
http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ardcXvHEekk/use-options-for-a-chance-to-buy-cldx-at-a-47-discount-cm475387
Use Options For a Chance To Buy CLDX at a 47% DiscountLooking back to 75 days ago, Celldex Therapeutics, Inc. (Symbol CLDX) priced a 7,250,000 share secondary stock offering at $24.00 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go<img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/ardcXvHEekk" height="1" width="1" alt=""/>Mon, 11 May 2015 17:20:16 Z2015-05-11T17:20:16Zhttp://www.nasdaq.com/article/use-options-for-a-chance-to-buy-cldx-at-a-47-discount-cm475387471686
http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JHGhoJo-cxY/alks-makes-notable-cross-below-critical-moving-average-cm471686
ALKS Makes Notable Cross Below Critical Moving AverageIn trading on Thursday, shares of Alkermes plc (Symbol ALKS) crossed below their 200 day moving average of $55.42, changing hands as low as $54.54 per share. Alkermes plc shares are currently trading off about 3.4% on the day.<img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/JHGhoJo-cxY" height="1" width="1" alt=""/>Thu, 30 Apr 2015 22:16:33 Z2015-04-30T22:16:33Zhttp://www.nasdaq.com/article/alks-makes-notable-cross-below-critical-moving-average-cm471686470258
http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3Xoa70irqr8/use-options-for-a-chance-to-buy-nvax-at-a-38-discount-cm470258
Use Options For a Chance To Buy NVAX at a 38% DiscountLooking back to 33 days ago, Novavax, Inc. (Symbol NVAX) priced a 24,137,931 share secondary stock offering at $7.25 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up<img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/3Xoa70irqr8" height="1" width="1" alt=""/>Tue, 28 Apr 2015 17:18:12 Z2015-04-28T17:18:12Zhttp://www.nasdaq.com/article/use-options-for-a-chance-to-buy-nvax-at-a-38-discount-cm470258468676
http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/n9qwJtympMo/use-options-for-a-chance-to-buy-alny-at-a-32-discount-cm468676
Use Options For a Chance To Buy ALNY at a 32% DiscountLooking back to 93 days ago, Alnylam Pharmaceuticals Inc (Symbol ALNY) priced a 4,736,842.00 share secondary stock offering at $95 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go<img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/n9qwJtympMo" height="1" width="1" alt=""/>Thu, 23 Apr 2015 17:23:58 Z2015-04-23T17:23:58Zhttp://www.nasdaq.com/article/use-options-for-a-chance-to-buy-alny-at-a-32-discount-cm468676